Conversely, RENT3B was downregulated in Invasive Breast Carcinoma, Esophageal Adenocarcinoma, Barrett’s Esophagus, Other Cancer (Yolk Sac Tumor), and Ovarian Carcinoma (Fig. 1A). Here, UPF3B is linked to nephrotic syndrome.